Soluble immune checkpoint molecules: Serum markers for cancer diagnosis and prognosis-Reference-Cited by-同舟云学术

Soluble immune checkpoint molecules: Serum markers for cancer diagnosis and prognosis

Published:2019-02-07 Issue: Volume: Page:e1160
ISSN:2573-8348
Container-title:CANCER REPORTS
language:en
Short-container-title:Cancer Reports

Author:

Chakrabarti Rituparna¹,Kapse Bhavya²,Mukherjee Gayatri¹^ORCID

Affiliation:

1. School of Medical Science and TechnologyIndian Institute of Technology Kharagpur Kharagpur India

2. Department of BiotechnologyIndian Institute of Technology Kharagpur Kharagpur India

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cnr2.1160

Reference161 articles.

1. From the immune contexture to the immunoscore: the role of prognostic and predictive immune markers in cancer;Angell H;Curr Opin Immunol,2013

2. Tumor‐derived exosomes and their role in cancer progression;Whiteside TL;Adv Clin Chem,2016

3. Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer;Mathé EA;Cancer Res,2014

4. Exosomal proteins as prognostic biomarkers in non‐small cell lung cancer;Sandfeld‐Paulsen B;Mol Oncol,2016

5. Comparison of quantification algorithms for circulating cell‐free DNA methylation biomarkers in blood plasma from cancer patients;Vos L;Clin Epigenetics,2017

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternative Strategies for Delivering Immunotherapeutics Targeting the PD-1/PD-L1 Immune Checkpoint in Cancer;Pharmaceutics;2024-09-07

2. Soluble immune checkpoint molecules in cancer risk, outcomes prediction, and therapeutic applications;Biomarker Research;2024-09-02

3. Targeting tumour metabolism in melanoma to enhance response to immune checkpoint inhibition: A balancing act;Cancer Treatment Reviews;2024-09

4. Peripheral immune biomarkers for immune checkpoint inhibition of solid tumours;Clinical and Translational Medicine;2024-08

5. Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8+ T cell exhaustion and anti-PD-1 resistance;Cell Reports Medicine;2024-08